2,869
edits
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
'''Co-use of 3,4-Methylenedioxy methamphetamine ([[MDMA]]) with [[psilocybin]] / [[magic mushrooms]] is termed '' | '''Co-use of 3,4-Methylenedioxy methamphetamine ([[MDMA]]) with [[psilocybin]] / [[magic mushrooms]] is termed ''hippie flipping''.''' It is thought that by combining MDMA with psilocybin this may reduce [[Adverse Psychedelic Effects|challenging experiences]] and enhances positive experiences associated with the medicine. Some evidence points <ref>'''Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences'''. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences</ref>to the use of low dose MDMA (50–75 mg) with psilocybin associates with significantly lower levels of total challenging experience. | ||
'''References''' | '''References''' |